NIH Conference on Tobacco Use Identifies Research Gaps
An NIH State-of-the-Science Conference on "Tobacco Use: Prevention, Cessation, and Control" issued a draft statement at the conclusion of its June 12-14 meeting that identifies the research, programs, and policies necessary to achieve further progress in reducing the individual and societal burdens of tobacco-related illnesses.
Dr. Mark Clanton, NCI deputy director and deputy director for Cancer Care Delivery Systems, stated, "We're here for this important and timely conference because tobacco prevention, treatment, and control research are so important to improving the nation's health. The purpose is to facilitate an objective review of the evidence: to clarify what is known and to identify what research gaps remain."
Panel Chairman Dr. David F. Ransohoff, of the University of North Carolina at Chapel Hill, stated that tobacco use remains the nation's leading preventable cause of premature death and that cigarette smoking alone is responsible for more than 30 percent of cancer deaths annually. Despite declines in tobacco use in recent decades, Dr. Ransohoff noted that "it is unlikely that the Healthy People 2010 objectives of reducing smoking prevalence to 12 percent or less in adults and 16 percent or less in youth will be reached on schedule." Read more
Using NCI's Expertise to Prepare for Avian Flu
Avian flu strain H5N1 represents a potentially devastating threat to public health in the United States, and preparation for its arrival on our shores is one of our nation's utmost priorities.
Responding to a potential public health threat from a virus is nothing new for NCI. Twenty-five years ago with the emergence of HIV/AIDS, the viral oncology expertise within NCI was mobilized, resulting in the successful development of therapies that have had global health impact on people living with HIV/AIDS. Read more